img

Global Interferon Beta-1a Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Interferon Beta-1a Market Insights, Forecast to 2034

Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Global Interferon Beta-1a market is expected to reach to US$ 4021 million in 2024, with a positive growth of %, compared with US$ 4324 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Interferon Beta-1a industry is evaluated to reach US$ 2584.8 million in 2029. The CAGR will be -7.1% during 2024 to 2029.
Interferon Beta-1a is a medication used for the treatment of relapsing forms of multiple sclerosis (MS). The market for Avonex is driven by factors such as the increasing prevalence of MS, the growing awareness about the disease, and advancements in MS treatment. Avonex is a well-established therapy with a proven track record of efficacy and safety. The market is also influenced by factors such as healthcare infrastructure development, favorable reimbursement policies, and the availability of generic alternatives. However, the market faces challenges such as competition from other MS treatments and the introduction of newer therapies. Despite these challenges, Avonex continues to hold a significant market share due to its established reputation and effectiveness. As research and development in the field of MS continue, the Avonex market is expected to witness moderate growth in the coming years.
Report Covers
This report presents an overview of global Interferon Beta-1a market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Interferon Beta-1a market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biogen
CinnaGen
Merck KGaA
Teva
Novartis
Bayer
Sanofi
Acorda Therapeutics
Mallinckrodt
Segment by Type
Subcutaneous
Intramuscular

Segment by Application


Hospital
Drugs Store
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Interferon Beta-1a plant distribution, commercial date of Interferon Beta-1a, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Interferon Beta-1a introduction, etc. Interferon Beta-1a Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Interferon Beta-1a
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Interferon Beta-1a Product Introduction
1.2 Market by Type
1.2.1 Global Interferon Beta-1a Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Subcutaneous
1.2.3 Intramuscular
1.3 Market by Application
1.3.1 Global Interferon Beta-1a Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Interferon Beta-1a Sales Estimates and Forecasts 2018-2029
2.2 Global Interferon Beta-1a Revenue by Region
2.2.1 Global Interferon Beta-1a Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Interferon Beta-1a Revenue by Region (2018-2024)
2.2.3 Global Interferon Beta-1a Revenue by Region (2024-2029)
2.2.4 Global Interferon Beta-1a Revenue Market Share by Region (2018-2029)
2.3 Global Interferon Beta-1a Sales Estimates and Forecasts 2018-2029
2.4 Global Interferon Beta-1a Sales by Region
2.4.1 Global Interferon Beta-1a Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Interferon Beta-1a Sales by Region (2018-2024)
2.4.3 Global Interferon Beta-1a Sales by Region (2024-2029)
2.4.4 Global Interferon Beta-1a Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Interferon Beta-1a Sales by Manufacturers
3.1.1 Global Interferon Beta-1a Sales by Manufacturers (2018-2024)
3.1.2 Global Interferon Beta-1a Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Interferon Beta-1a in 2022
3.2 Global Interferon Beta-1a Revenue by Manufacturers
3.2.1 Global Interferon Beta-1a Revenue by Manufacturers (2018-2024)
3.2.2 Global Interferon Beta-1a Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Interferon Beta-1a Revenue in 2022
3.3 Global Key Players of Interferon Beta-1a, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Interferon Beta-1a Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Interferon Beta-1a Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Interferon Beta-1a, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Interferon Beta-1a, Product Offered and Application
3.8 Global Key Manufacturers of Interferon Beta-1a, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Interferon Beta-1a Sales by Type
4.1.1 Global Interferon Beta-1a Historical Sales by Type (2018-2024)
4.1.2 Global Interferon Beta-1a Forecasted Sales by Type (2024-2029)
4.1.3 Global Interferon Beta-1a Sales Market Share by Type (2018-2029)
4.2 Global Interferon Beta-1a Revenue by Type
4.2.1 Global Interferon Beta-1a Historical Revenue by Type (2018-2024)
4.2.2 Global Interferon Beta-1a Forecasted Revenue by Type (2024-2029)
4.2.3 Global Interferon Beta-1a Revenue Market Share by Type (2018-2029)
4.3 Global Interferon Beta-1a Price by Type
4.3.1 Global Interferon Beta-1a Price by Type (2018-2024)
4.3.2 Global Interferon Beta-1a Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Interferon Beta-1a Sales by Application
5.1.1 Global Interferon Beta-1a Historical Sales by Application (2018-2024)
5.1.2 Global Interferon Beta-1a Forecasted Sales by Application (2024-2029)
5.1.3 Global Interferon Beta-1a Sales Market Share by Application (2018-2029)
5.2 Global Interferon Beta-1a Revenue by Application
5.2.1 Global Interferon Beta-1a Historical Revenue by Application (2018-2024)
5.2.2 Global Interferon Beta-1a Forecasted Revenue by Application (2024-2029)
5.2.3 Global Interferon Beta-1a Revenue Market Share by Application (2018-2029)
5.3 Global Interferon Beta-1a Price by Application
5.3.1 Global Interferon Beta-1a Price by Application (2018-2024)
5.3.2 Global Interferon Beta-1a Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Interferon Beta-1a Market Size by Type
6.1.1 US & Canada Interferon Beta-1a Sales by Type (2018-2029)
6.1.2 US & Canada Interferon Beta-1a Revenue by Type (2018-2029)
6.2 US & Canada Interferon Beta-1a Market Size by Application
6.2.1 US & Canada Interferon Beta-1a Sales by Application (2018-2029)
6.2.2 US & Canada Interferon Beta-1a Revenue by Application (2018-2029)
6.3 US & Canada Interferon Beta-1a Market Size by Country
6.3.1 US & Canada Interferon Beta-1a Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Interferon Beta-1a Sales by Country (2018-2029)
6.3.3 US & Canada Interferon Beta-1a Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Interferon Beta-1a Market Size by Type
7.1.1 Europe Interferon Beta-1a Sales by Type (2018-2029)
7.1.2 Europe Interferon Beta-1a Revenue by Type (2018-2029)
7.2 Europe Interferon Beta-1a Market Size by Application
7.2.1 Europe Interferon Beta-1a Sales by Application (2018-2029)
7.2.2 Europe Interferon Beta-1a Revenue by Application (2018-2029)
7.3 Europe Interferon Beta-1a Market Size by Country
7.3.1 Europe Interferon Beta-1a Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Interferon Beta-1a Sales by Country (2018-2029)
7.3.3 Europe Interferon Beta-1a Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Interferon Beta-1a Market Size
8.1.1 China Interferon Beta-1a Sales (2018-2029)
8.1.2 China Interferon Beta-1a Revenue (2018-2029)
8.2 China Interferon Beta-1a Market Size by Application
8.2.1 China Interferon Beta-1a Sales by Application (2018-2029)
8.2.2 China Interferon Beta-1a Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Interferon Beta-1a Market Size by Type
9.1.1 Asia Interferon Beta-1a Sales by Type (2018-2029)
9.1.2 Asia Interferon Beta-1a Revenue by Type (2018-2029)
9.2 Asia Interferon Beta-1a Market Size by Application
9.2.1 Asia Interferon Beta-1a Sales by Application (2018-2029)
9.2.2 Asia Interferon Beta-1a Revenue by Application (2018-2029)
9.3 Asia Interferon Beta-1a Sales by Region
9.3.1 Asia Interferon Beta-1a Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Interferon Beta-1a Revenue by Region (2018-2029)
9.3.3 Asia Interferon Beta-1a Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Interferon Beta-1a Market Size by Type
10.1.1 Middle East, Africa and Latin America Interferon Beta-1a Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Interferon Beta-1a Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Interferon Beta-1a Market Size by Application
10.2.1 Middle East, Africa and Latin America Interferon Beta-1a Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Interferon Beta-1a Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Interferon Beta-1a Sales by Country
10.3.1 Middle East, Africa and Latin America Interferon Beta-1a Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Interferon Beta-1a Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Interferon Beta-1a Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Overview
11.1.3 Biogen Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Biogen Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biogen Recent Developments
11.2 CinnaGen
11.2.1 CinnaGen Company Information
11.2.2 CinnaGen Overview
11.2.3 CinnaGen Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CinnaGen Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CinnaGen Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Overview
11.3.3 Merck KGaA Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merck KGaA Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck KGaA Recent Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Overview
11.4.3 Teva Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Teva Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer Overview
11.6.3 Bayer Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bayer Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sanofi Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Acorda Therapeutics
11.8.1 Acorda Therapeutics Company Information
11.8.2 Acorda Therapeutics Overview
11.8.3 Acorda Therapeutics Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Acorda Therapeutics Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Acorda Therapeutics Recent Developments
11.9 Mallinckrodt
11.9.1 Mallinckrodt Company Information
11.9.2 Mallinckrodt Overview
11.9.3 Mallinckrodt Interferon Beta-1a Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Mallinckrodt Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Mallinckrodt Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Interferon Beta-1a Industry Chain Analysis
12.2 Interferon Beta-1a Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Interferon Beta-1a Production Mode & Process
12.4 Interferon Beta-1a Sales and Marketing
12.4.1 Interferon Beta-1a Sales Channels
12.4.2 Interferon Beta-1a Distributors
12.5 Interferon Beta-1a Customers
13 Market Dynamics
13.1 Interferon Beta-1a Industry Trends
13.2 Interferon Beta-1a Market Drivers
13.3 Interferon Beta-1a Market Challenges
13.4 Interferon Beta-1a Market Restraints
14 Key Findings in The Global Interferon Beta-1a Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Interferon Beta-1a Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Subcutaneous
Table 3. Major Manufacturers of Intramuscular
Table 4. Global Interferon Beta-1a Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Interferon Beta-1a Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Interferon Beta-1a Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Interferon Beta-1a Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Interferon Beta-1a Revenue Market Share by Region (2018-2024)
Table 9. Global Interferon Beta-1a Revenue Market Share by Region (2024-2029)
Table 10. Global Interferon Beta-1a Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Interferon Beta-1a Sales by Region (2018-2024) & (K Units)
Table 12. Global Interferon Beta-1a Sales by Region (2024-2029) & (K Units)
Table 13. Global Interferon Beta-1a Sales Market Share by Region (2018-2024)
Table 14. Global Interferon Beta-1a Sales Market Share by Region (2024-2029)
Table 15. Global Interferon Beta-1a Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Interferon Beta-1a Sales Share by Manufacturers (2018-2024)
Table 17. Global Interferon Beta-1a Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Interferon Beta-1a Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Interferon Beta-1a, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Interferon Beta-1a Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Interferon Beta-1a Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Interferon Beta-1a by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interferon Beta-1a as of 2022)
Table 23. Global Key Manufacturers of Interferon Beta-1a, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Interferon Beta-1a, Product Offered and Application
Table 25. Global Key Manufacturers of Interferon Beta-1a, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 28. Global Interferon Beta-1a Sales by Type (2024-2029) & (K Units)
Table 29. Global Interferon Beta-1a Sales Share by Type (2018-2024)
Table 30. Global Interferon Beta-1a Sales Share by Type (2024-2029)
Table 31. Global Interferon Beta-1a Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Interferon Beta-1a Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Interferon Beta-1a Revenue Share by Type (2018-2024)
Table 34. Global Interferon Beta-1a Revenue Share by Type (2024-2029)
Table 35. Interferon Beta-1a Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Interferon Beta-1a Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Interferon Beta-1a Sales by Application (2018-2024) & (K Units)
Table 38. Global Interferon Beta-1a Sales by Application (2024-2029) & (K Units)
Table 39. Global Interferon Beta-1a Sales Share by Application (2018-2024)
Table 40. Global Interferon Beta-1a Sales Share by Application (2024-2029)
Table 41. Global Interferon Beta-1a Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Interferon Beta-1a Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Interferon Beta-1a Revenue Share by Application (2018-2024)
Table 44. Global Interferon Beta-1a Revenue Share by Application (2024-2029)
Table 45. Interferon Beta-1a Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Interferon Beta-1a Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Interferon Beta-1a Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Interferon Beta-1a Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Interferon Beta-1a Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Interferon Beta-1a Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Interferon Beta-1a Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Interferon Beta-1a Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Interferon Beta-1a Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Interferon Beta-1a Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Interferon Beta-1a Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Interferon Beta-1a Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Interferon Beta-1a Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Interferon Beta-1a Sales by Country (2024-2029) & (K Units)
Table 60. Europe Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 61. Europe Interferon Beta-1a Sales by Type (2024-2029) & (K Units)
Table 62. Europe Interferon Beta-1a Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Interferon Beta-1a Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Interferon Beta-1a Sales by Application (2018-2024) & (K Units)
Table 65. Europe Interferon Beta-1a Sales by Application (2024-2029) & (K Units)
Table 66. Europe Interferon Beta-1a Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Interferon Beta-1a Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Interferon Beta-1a Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Interferon Beta-1a Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Interferon Beta-1a Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Interferon Beta-1a Sales by Country (2018-2024) & (K Units)
Table 72. Europe Interferon Beta-1a Sales by Country (2024-2029) & (K Units)
Table 73. China Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 74. China Interferon Beta-1a Sales by Type (2024-2029) & (K Units)
Table 75. China Interferon Beta-1a Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Interferon Beta-1a Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Interferon Beta-1a Sales by Application (2018-2024) & (K Units)
Table 78. China Interferon Beta-1a Sales by Application (2024-2029) & (K Units)
Table 79. China Interferon Beta-1a Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Interferon Beta-1a Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 82. Asia Interferon Beta-1a Sales by Type (2024-2029) & (K Units)
Table 83. Asia Interferon Beta-1a Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Interferon Beta-1a Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Interferon Beta-1a Sales by Application (2018-2024) & (K Units)
Table 86. Asia Interferon Beta-1a Sales by Application (2024-2029) & (K Units)
Table 87. Asia Interferon Beta-1a Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Interferon Beta-1a Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Interferon Beta-1a Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Interferon Beta-1a Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Interferon Beta-1a Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Interferon Beta-1a Sales by Region (2018-2024) & (K Units)
Table 93. Asia Interferon Beta-1a Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Interferon Beta-1a Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Interferon Beta-1a Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Interferon Beta-1a Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Interferon Beta-1a Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Interferon Beta-1a Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Interferon Beta-1a Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Interferon Beta-1a Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Interferon Beta-1a Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Interferon Beta-1a Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Interferon Beta-1a Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Interferon Beta-1a Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Interferon Beta-1a Sales by Country (2024-2029) & (K Units)
Table 107. Biogen Company Information
Table 108. Biogen Description and Major Businesses
Table 109. Biogen Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Biogen Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Biogen Recent Developments
Table 112. CinnaGen Company Information
Table 113. CinnaGen Description and Major Businesses
Table 114. CinnaGen Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. CinnaGen Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CinnaGen Recent Developments
Table 117. Merck KGaA Company Information
Table 118. Merck KGaA Description and Major Businesses
Table 119. Merck KGaA Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Merck KGaA Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Merck KGaA Recent Developments
Table 122. Teva Company Information
Table 123. Teva Description and Major Businesses
Table 124. Teva Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Teva Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Teva Recent Developments
Table 127. Novartis Company Information
Table 128. Novartis Description and Major Businesses
Table 129. Novartis Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Novartis Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novartis Recent Developments
Table 132. Bayer Company Information
Table 133. Bayer Description and Major Businesses
Table 134. Bayer Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Bayer Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bayer Recent Developments
Table 137. Sanofi Company Information
Table 138. Sanofi Description and Major Businesses
Table 139. Sanofi Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Sanofi Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Sanofi Recent Developments
Table 142. Acorda Therapeutics Company Information
Table 143. Acorda Therapeutics Description and Major Businesses
Table 144. Acorda Therapeutics Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Acorda Therapeutics Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Acorda Therapeutics Recent Developments
Table 147. Mallinckrodt Company Information
Table 148. Mallinckrodt Description and Major Businesses
Table 149. Mallinckrodt Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Mallinckrodt Interferon Beta-1a Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Mallinckrodt Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Interferon Beta-1a Distributors List
Table 155. Interferon Beta-1a Customers List
Table 156. Interferon Beta-1a Market Trends
Table 157. Interferon Beta-1a Market Drivers
Table 158. Interferon Beta-1a Market Challenges
Table 159. Interferon Beta-1a Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Beta-1a Product Picture
Figure 2. Global Interferon Beta-1a Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Interferon Beta-1a Market Share by Type in 2022 & 2029
Figure 4. Subcutaneous Product Picture
Figure 5. Intramuscular Product Picture
Figure 6. Global Interferon Beta-1a Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Interferon Beta-1a Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Other
Figure 11. Interferon Beta-1a Report Years Considered
Figure 12. Global Interferon Beta-1a Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Interferon Beta-1a Revenue 2018-2029 (US$ Million)
Figure 14. Global Interferon Beta-1a Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Interferon Beta-1a Revenue Market Share by Region (2018-2029)
Figure 16. Global Interferon Beta-1a Sales 2018-2029 ((K Units)
Figure 17. Global Interferon Beta-1a Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Interferon Beta-1a Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Interferon Beta-1a Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Interferon Beta-1a Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Interferon Beta-1a Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Interferon Beta-1a Sales YoY (2018-2029) & (K Units)
Figure 23. China Interferon Beta-1a Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Interferon Beta-1a Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Interferon Beta-1a Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Interferon Beta-1a Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Interferon Beta-1a Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Interferon Beta-1a Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Interferon Beta-1a in the World: Market Share by Interferon Beta-1a Revenue in 2022
Figure 30. Global Interferon Beta-1a Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Interferon Beta-1a Sales Market Share by Type (2018-2029)
Figure 32. Global Interferon Beta-1a Revenue Market Share by Type (2018-2029)
Figure 33. Global Interferon Beta-1a Sales Market Share by Application (2018-2029)
Figure 34. Global Interferon Beta-1a Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Interferon Beta-1a Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Interferon Beta-1a Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Interferon Beta-1a Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Interferon Beta-1a Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Interferon Beta-1a Revenue Share by Country (2018-2029)
Figure 40. US & Canada Interferon Beta-1a Sales Share by Country (2018-2029)
Figure 41. U.S. Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Interferon Beta-1a Sales Market Share by Type (2018-2029)
Figure 44. Europe Interferon Beta-1a Revenue Market Share by Type (2018-2029)
Figure 45. Europe Interferon Beta-1a Sales Market Share by Application (2018-2029)
Figure 46. Europe Interferon Beta-1a Revenue Market Share by Application (2018-2029)
Figure 47. Europe Interferon Beta-1a Revenue Share by Country (2018-2029)
Figure 48. Europe Interferon Beta-1a Sales Share by Country (2018-2029)
Figure 49. Germany Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 50. France Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 51. UK Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 54. China Interferon Beta-1a Sales Market Share by Type (2018-2029)
Figure 55. China Interferon Beta-1a Revenue Market Share by Type (2018-2029)
Figure 56. China Interferon Beta-1a Sales Market Share by Application (2018-2029)
Figure 57. China Interferon Beta-1a Revenue Market Share by Application (2018-2029)
Figure 58. Asia Interferon Beta-1a Sales Market Share by Type (2018-2029)
Figure 59. Asia Interferon Beta-1a Revenue Market Share by Type (2018-2029)
Figure 60. Asia Interferon Beta-1a Sales Market Share by Application (2018-2029)
Figure 61. Asia Interferon Beta-1a Revenue Market Share by Application (2018-2029)
Figure 62. Asia Interferon Beta-1a Revenue Share by Region (2018-2029)
Figure 63. Asia Interferon Beta-1a Sales Share by Region (2018-2029)
Figure 64. Japan Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 68. India Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Interferon Beta-1a Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Interferon Beta-1a Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Interferon Beta-1a Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Interferon Beta-1a Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Interferon Beta-1a Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Interferon Beta-1a Sales Share by Country (2018-2029)
Figure 75. Brazil Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Interferon Beta-1a Revenue (2018-2029) & (US$ Million)
Figure 80. Interferon Beta-1a Value Chain
Figure 81. Interferon Beta-1a Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries